Skip to main content

Table 3 Prevalence of different types of chronic kidney disease and associated variables in the 1478 diabetic patients in wich CRI and albuminuria data were available

From: Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area

  Albuminuria without renal impairment Nonalbuminuric renal impairment
n,(%) 200 (13.5) 217 (14.7)
Age, mean (SD) 67.49 (11.89) 72.35 (9.94)a
Gender, men (%) 137 (68.5) 75 (34.6)a
Type 2 DM duration, years (SD) 7.13 (4.89) 8.41 (6.43)a
Obesity, n (%) 75 (44.4) 79 (39.3)a
BP, mmHg (SD) 139.79/77.79 (15.22/9.35) 138.12/75.38 (14.22/8.72)b
HbA1c, mean (SD) 7.27 (1.61) 6.68 (1.42)a
Total cholesterol, mean (SD) 187.74 (37.38) 193.17 (36.66)
Non-HDL cholesterol, mg/dl, mean (SD) 141.75 (34.89) 141.81 (35.75)
Creatinine, mg/dl (SD) 0.87 (0.17) 2.38 (1.60)a
GFR, mil/min/1.73 m 2 (SD) 92.49 (58.24) 36.55 (19.28)a
Tobacco, n (%) 34 (18.1) 15 (7.0)b
Macrovascular disease, n (%) 46 (23.8) 33 (15.4)a
CHD,n (%) 37 (19.2) 21 (9.8)a
Stroke, n (%) 10 (5.2) 15 (6.9)
Diabetic retinopathy, n (%) 23 (20.2) 25 (18.9)
Insulin treatment, n (%) 43 (22.0) 43 (19.9)
Calibrated Framingham CV risk eq. & 10%, n (%) 14 (10.4) 7 (6.3)
  1. BP: blood pressure; HDL: high density lipoprotein, GFR: glomerular filtration rate, CHD: coronary heart disease, CV: cardiovascular RI: renal impairment.
  2. Albuminuria without RI vs. Nonalbuminuric RI: a p <0.001; b p < 0.05.